Digital Diabetes Management Market Positioned for 20% Growth by 202

BRUSSELS - Oct. 5, 2023 - PRLog -- Diabetes is a chronic disease that must be constantly managed. Diabetes patients who need to make lifestyle or pharmaceutical changes in response to glucose monitoring data might benefit from digital diabetes management systems.

Demand is being fueled by technological advancements in digital diabetes management market

For instance,

In March 2022, Glooko Inc. acquired DIABNEXT to increase its diabetes offerings in France. DIABNEXT's mobile app complements Glooko's product portfolio and tracks diabetes data

In February 2022, Terumo Corporation entered into an agreement with Diabeloop.

Growing Awareness Regarding Diabetes Self-Management Solutions

Diabetes self-management encompasses diabetes education, healthy eating, physical exercise, medication, device use, monitoring, and adjusting behavior and drug dosages based on patient-generated data. e,

Diabetes Self-Management Training (DSMT) Certification

Diabetes Self-Management Education and Support (DSMES) services

World Diabetes Day (WDD) is the world's largest diabetes awareness campaign

Role of mHealth in Digital Diabetes Management Market Increases Demand

Diabetes is the most often addressed chronic clinical ailment by mHealth, followed by depression and asthma. Mobile health (mHealth) solutions have improved diabetes care and prevention and are expected to play a growing role as smartphone ownership and medical device developments increase. For instance,

In May 2021, F. Hoffmann-la Roche joined up with Ellerca Health to launch Accu-Chek + 360Care.

North America to dominant the digital diabetes management market

North America now controls a sizable portion of the worldwide digital diabetes management industry. North America is likely to maintain a significant position in the coming years, owing to the region's rising diabetes incidence and increased use of technologically sophisticated devices.

Competitive Landscape Analysis of the Digital Diabetes Management Market

Some of the key players competing in the market include Medtronic Plc, Abbott, F.Hoffmann-LA Roche Ltd, Senseonics, and Insulet Corporation, among others.

Organic and inorganic growth strategies used by firms to get a foothold in the Digital Diabetes Management Market

Players in this market are employing organic and inorganic growth strategies such as collaborations, acquisitions, and new product launches to obtain market share. For instance,

In April 2022, Dexcom released Dexcom ONE Continuous Glucose Monitoring System. The Dexcom ONE system is an easy-to-use real-time CGM (rt-CGM) that more cheaper and accessible for people with diabetes in the UK

In April 2022, Abbott announced a collaboration with CamDiab and Ypsomed. The three businesses want to collaborate to develop and market an integrated automated insulin delivery (AID) system.

Explore Comprehensive Market insights on Digital Diabetes Management Market, Vist Us On @ https://meditechinsights.com/digital-diabetes-management-market/